SCHEMBL574542

SCHEMBL574542

CCN(CC)c1cc(C(=O)O)cc(S(N)(=O)=O)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PKM P14618 1/20 0.42
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
HCAR3 P49019 1/20 0.40
CA2 P00918 12/20 0.40
CA1 P00915 11/20 0.40
CISD1 Q9NZ45 4/20 0.40
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
CA3 P07451 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
CA5A P35218 1/20 0.40
CA7 P43166 1/20 0.40
CA13 Q8N1Q1 1/20 0.40
CA14 Q9ULX7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574554 0.86 CISD1 (0.43) KMT2ASMN1; SMN2PKMALDH1A1CYP1A2
SCHEMBL574056 0.83 PKM (0.45) KMT2ASMN1; SMN2PKMALDH1A1CYP1A2
SCHEMBL574683 0.77 ALDH1A1 (0.60) KMT2ASMN1; SMN2PKMALDH1A1HCAR3
SCHEMBL9042101 0.76 CA1 (0.56) PKMALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL9737103 0.76 CA2 (0.39) KMT2ASMN1; SMN2PKMALDH1A1CA2
SCHEMBL9738547 0.76 CA2 (0.39) KMT2ASMN1; SMN2PKMALDH1A1CA2
SCHEMBL574173 0.75 CA2 (0.47) PKMALDH1A1CA2CA1CISD1
SCHEMBL2880823 0.74 CDC25B (0.47) PKMALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL11756625 0.74 CA1 (0.47) PKMALDH1A1CYP1A2CYP2D6CYP2C19
Bromide SCHEMBL10829371 0.73 CA1 (0.42) ALDH1A1CYP1A2CYP2D6CYP2C19CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed